Back to Top Skip to main content Skip to sub-navigation

Marines, Sailors with PHIBRON 11, 31st MEU receive COVID-19 vaccine

Military health personnel giving the COVID-19 Vaccine to military personnel Navy Hospital Corpsman 1st Class Javier Flores injects a COVID-19 vaccination to Navy Retail Specialist Seaman Jordan Davis aboard amphibious transport dock ship USS New Orleans. New Orleans, part of the America Expeditionary Strike Group, along with the 31st Marine Expeditionary Unit, is operating in the U.S. 7th Fleet area of responsibility (U.S. Navy photo by Petty Officer 2nd Class Kelby Sanders).

Recommended Content:

Coronavirus | Immunization Healthcare | COVID-19 Vaccine Efforts

In a critical move for readiness, resiliency and safety, ships of Amphibious Squadron (PHIBRON) 11 received their first dose of the Moderna COVID-19 vaccine last weekend in Okinawa, Japan.

The amphibious transport dock USS New Orleans, along with the amphibious dock landing ships USS Germantown and USS Ashland, in cooperation with U.S. Naval Hospital Okinawa and the embarked 31st Marine Expeditionary Unit, rolled up their sleeves for their first dose of the vaccine.

“As the premier crisis response force in the Indo-Pacific, we have to be ready to respond to the region’s needs at a moment’s notice,” said Navy Capt. Richard LeBron, PHIBRON 11 commodore. “The better protected we are against the coronavirus, the greater assurance I can give our fleet commanders that our ships, Sailors and Marines are without a doubt always here and always ready to fight and deliver when called upon.

“Doing our part to help sink COVID is a huge step for these three ships as they continue to operate throughout the AOR, execute complex and challenging missions, and interact with our allies and partners,” said LeBron.

Vaccination for service members is voluntary, as vaccines are currently authorized for emergency use. Aboard New Orleans, the vast majority of the crew chose to receive the shot.

“The New Orleans crew has shown exceptional resilience in facing COVID-19 over the past year,” said Navy Capt. Brian Schrum, the ship’s commanding officer. “This vaccine will keep our Sailors safe, ready, and confident in our ability to operate forward and overcome any challenges we may encounter.”

Germantown, which recently celebrated the 35th anniversary of the ship’s commissioning, also saw the majority of the crew elect to get the vaccine.

“Following a concerted educational campaign led by our medical team, most of the crew chose to receive the vaccine,” said Navy Cmdr. Cullen Greenfield, Germantown’s commanding officer. “The pandemic has brought many trials, but the Germantown and her crew are resilient, flexible, and creative in meeting those challenges – we expect the vaccine will improve our ability to remain a ready force, stay healthy and operational, and sink COVID.”

According to the Center for Disease Control and Prevention, those receiving the Moderna vaccine should receive the second dose 28 days after the first dose.

“Once a Sailor or Marine is fully vaccinated with both their first and second dose of the Moderna vaccine, they should expect over ninety-four percent efficacy in preventing disease from COVID-19, which will virtually eliminate the risk of severe disease or death during an outbreak at sea,” said Navy Cmdr. Hamilton Tilley, Expeditionary Strike Group 7’s task force surgeon. “Receiving just the first vaccine dose gives significant protection and is the first step in not only protecting themselves but their family as well as fellow Sailors and Marines.”

Amphibious Squadron 11, the Navy’s only forward-deployed amphibious squadron, along with embarked Marines from the 31st Marine Expeditionary Unit, is operating in the U.S. 7th Fleet area of responsibility to enhance interoperability with allies and partners, and serve as a ready response force to defend peace and stability in the Indo-Pacific region.

You also may be interested in...

Inclusion of the Measles Mumps and Rubella Vaccine

Report
12/11/2010

Defense Health Board: Inclusion of the Measles Mumps and Rubella Vaccine

Recommended Content:

Immunizations | Immunization Healthcare

Accomplishments and Critical Lessons Learned Regarding Department of Defense H1N1 Influenza Report

Presentation
11/2/2010

Accomplishments and Critical Lessons Learned Regarding Department of Defense H1N1 Influenza Report briefing presented to the Defense Health Board Nov. 2, 2010

Recommended Content:

Immunizations | Immunization Healthcare

Measles Mumps Rubella and Smallpox Anthrax Vaccine Recommendations

Presentation
8/18/2010

Measles Mumps Rubella and Smallpox Anthrax Vaccine Recommendations briefing presented to the Defense Health Board Aug. 18, 2010

Recommended Content:

Immunizations | Immunization Healthcare

Inclusion of Measles Mumps Rubella Vaccine in Navy Accessions Screening and Immunizations Program

Presentation
6/8/2010

Inclusion of Measles Mumps Rubella Vaccine in Navy Accessions Screening and Immunizations Program briefing presented to the Defense Health Board June 8, 2010

Recommended Content:

Immunizations | Immunization Healthcare

Joint Preventive Medicine Policy Group Response to the Pandemic Influenza Preparedness and Response

Presentation
3/1/2010

Joint Preventive Medicine Policy Group Response to the Pandemic Influenza Preparedness and Response briefing presented to the Defense Health Board March 1, 2010

Recommended Content:

Immunizations | Immunization Healthcare

Influenza Update

Presentation
11/12/2009

Influenza Update presented to the Defense Health Board Nov. 12, 2009

Recommended Content:

Immunization Healthcare

Defense Health Board Recommendations Pertaining to Pandemic Influenza Preparedness and Response

Report
9/11/2009

Defense Health Board: Defense Health Board Recommendations Pertaining to Pandemic Influenza Preparedness and Response

Recommended Content:

Immunization Healthcare

Review of Pandemic Influenza Preparedness Subpanel Recommendations

Presentation
8/17/2009

Review of Pandemic Influenza Preparedness Subpanel Recommendations presented to the Defense Health Board Aug. 17, 2009

Recommended Content:

Immunization Healthcare | Immunizations

Clinical Policy for the Administration of the Anthrax Vaccine Adsorbed

Policy

Transfer Storage and Oversight of the Warren AFB Cohort Serum Repository and Data Assets

Report
7/8/2009

Defense Health Board: Transfer Storage and Oversight of the Warren AFB Cohort Serum Repository and Data Assets

Recommended Content:

Immunizations | Immunization Healthcare

Vaccine Safety and Effectiveness Recommendation Memo

Report
6/4/2009

Defense Health Board: Vaccine Safety and Effectiveness Recommendation Memo

Recommended Content:

Immunizations | Immunization Healthcare | Research and Innovation

Vaccine Safety and Effectiveness Report

Presentation
5/7/2009

Vaccine Safety and Effectiveness Report presented to the Defense Health Board May 7, 2009

Recommended Content:

Immunizations | Immunization Healthcare

Department of Defense Guidance Regarding Thimerosal Containing Vaccines

Policy

This memo provides guidance regarding the use of vaccines containing Thimerosal.

Vaccine Safety and Effectiveness Workgroup Update

Presentation
9/4/2008

Vaccine Safety and Effectiveness Workgroup Update presented to the Defense Health Board Sept. 4, 2008

Recommended Content:

Immunizations | Immunization Healthcare

Off Label Vaccine Use and Vaccination of Military Recruits During Summer Months

Report
5/5/2008

Defense Health Board: Off Label Vaccine Use and Vaccination of Military Recruits During Summer Months

Recommended Content:

Immunization Healthcare | Immunizations
<< < ... 41 42 43 > >> 
Showing results 616 - 630 Page 42 of 43

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.